DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Methylmalonic Acid is an investigational drug.
There have been 14 clinical trials for Methylmalonic Acid. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2006.
The most common disease conditions in clinical trials are Amino Acid Metabolism, Inborn Errors, Vitamin B 12 Deficiency, and Propionic Acidemia. The leading clinical trial sponsors are Mendel Tuchman, University of California, Los Angeles, and University Hospitals Cleveland Medical Center.
Recent Clinical Trials for Methylmalonic Acid
|Long-term Efficacy of Carglumic Acid in Organic Acidemia.||National Taiwan University Hospital||N/A|
|Carglumic Acid in Methylmalonic Acidemia and Propionic Acidemia||King Abdullah International Medical Research Center||Phase 3|
|EPI-743 in Cobalamin C Defect: Effects on Visual and Neurological Impairment||Catholic University of the Sacred Heart||Phase 2|